Literature DB >> 21454496

Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization.

Valeriy V Lyzogubov1, Ruslana G Tytarenko, Juan Liu, Nalini S Bora, Puran S Bora.   

Abstract

In this study, we describe a new method for inducing choroidal neovascularization (CNV) in C57BL/6 mice, an animal model of wet age-related macular degeneration (AMD). AMD is a disease that causes central blindness in humans. We injected PEG-8 subretinally in different doses (0.125-2 mg) to induce CNV. After PEG-8 injection, we examined CNV at several time points (days 3-42). We also used Western blotting, immunohistochemistry, and ELISA to examine the complement component C3 split products, C9, VEGF, TGF-β2, and basic FGF. As early as day 1 after treatment, we found that a single subretinal injection of 1 mg of PEG-8 increased the C3 split products and the C9, TGF-β2, and basic FGF levels in the retinal pigment epithelium-choroid tissue. By day 3 after PEG-8 injection, the intraocular activation of the complement system caused induction and progression of CNV, including new vessels penetrating the Bruch's membrane. At day 5 after PEG-8 injection, we observed a fully developed CNV and retinal degeneration. Thus, in this study, we present a new, inexpensive, and accelerated mouse model of CNV that may be useful to study AMD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454496      PMCID: PMC3091230          DOI: 10.1074/jbc.M110.204701

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Review of the ocular angiogenesis animal models.

Authors:  Sandra R Montezuma; Demetrios Vavvas; Joan W Miller
Journal:  Semin Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.975

2.  Angiogenesis in early choroidal neovascularization secondary to age-related macular degeneration.

Authors:  M C Killingsworth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-06       Impact factor: 3.117

3.  Clinical and histological aspects of CNV formation: studies in an animal model.

Authors:  Nathan Lassota
Journal:  Acta Ophthalmol       Date:  2008-09       Impact factor: 3.761

4.  Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury.

Authors:  Joshua M Thurman; Brandon Renner; Kannan Kunchithapautham; Viviana P Ferreira; Michael K Pangburn; Zsolt Ablonczy; Stephen Tomlinson; V Michael Holers; Bärbel Rohrer
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

5.  A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.

Authors:  Bärbel Rohrer; Qin Long; Beth Coughlin; R Brooks Wilson; Yuxiang Huang; Fei Qiao; Peter H Tang; Kannan Kunchithapautham; Gary S Gilkeson; Stephen Tomlinson
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

6.  Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE.

Authors:  Kasmir Ramo; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

7.  Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.

Authors:  I Hamad; A C Hunter; J Szebeni; S M Moghimi
Journal:  Mol Immunol       Date:  2008-10-11       Impact factor: 4.407

8.  A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.

Authors:  Yuxiang Huang; Fei Qiao; Carl Atkinson; V Michael Holers; Stephen Tomlinson
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

9.  Age-related macular degeneration.

Authors:  Hanna R Coleman; Chi-Chao Chan; Frederick L Ferris; Emily Y Chew
Journal:  Lancet       Date:  2008-11-22       Impact factor: 79.321

10.  Upregulation of VEGF in murine retina via monocyte recruitment after retinal scatter laser photocoagulation.

Authors:  Masahiro Itaya; Eiji Sakurai; Miho Nozaki; Kiyoshi Yamada; Satoshi Yamasaki; Kiyofumi Asai; Yuichiro Ogura
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-12       Impact factor: 4.799

View more
  25 in total

Review 1.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

Review 2.  Clinical promise of next-generation complement therapeutics.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Rev Drug Discov       Date:  2019-07-19       Impact factor: 84.694

3.  Safety Assessment of Formulation Vehicles Following Intravitreal Administration in Rabbits.

Authors:  Shirley A Aguirre; Hovhannes J Gukasyan; Husam S Younis; Wenhu Huang
Journal:  Pharm Res       Date:  2018-07-09       Impact factor: 4.200

4.  The effect of nicotine on anti-vascular endothelial growth factor therapy in a mouse model of neovascular age-related macular degeneration.

Authors:  Stephen J Davis; Valeriy V Lyzogubov; Ruslana G Tytarenko; Ammar N Safar; Nalini S Bora; Puran S Bora
Journal:  Retina       Date:  2012-06       Impact factor: 4.256

Review 5.  Subretinal injection in mice to study retinal physiology and disease.

Authors:  Peirong Huang; Siddharth Narendran; Felipe Pereira; Shinichi Fukuda; Yosuke Nagasaka; Ivana Apicella; Praveen Yerramothu; Kenneth M Marion; Xiaoyu Cai; Srinivas R Sadda; Bradley D Gelfand; Jayakrishna Ambati
Journal:  Nat Protoc       Date:  2022-04-13       Impact factor: 13.491

6.  Complement regulatory protein CD46 protects against choroidal neovascularization in mice.

Authors:  Valeriy Lyzogubov; Xiaobo Wu; Purushottam Jha; Ruslana Tytarenko; Michael Triebwasser; Grant Kolar; Paula Bertram; Puran S Bora; John P Atkinson; Nalini S Bora
Journal:  Am J Pathol       Date:  2014-07-11       Impact factor: 4.307

7.  The Complement Regulatory Protein CD46 Deficient Mouse Spontaneously Develops Dry-Type Age-Related Macular Degeneration-Like Phenotype.

Authors:  Valeriy V Lyzogubov; Puran S Bora; Xiaobo Wu; Leah E Horn; Ryan de Roque; Xeniya V Rudolf; John P Atkinson; Nalini S Bora
Journal:  Am J Pathol       Date:  2016-06-11       Impact factor: 4.307

8.  Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primates.

Authors:  Sarah Hughes; Justin Gumas; Rebecca Lee; Merita Rumano; Nadja Berger; Avneesh Kumar Gautam; Georgia Sfyroera; Anna Lorena Chan; Gopalan Gnanaguru; Kip M Connor; Benjamin J Kim; Joshua L Dunaief; Daniel Ricklin; George Hajishengallis; Despina Yancopoulou; Edimara S Reis; Dimitrios C Mastellos; John D Lambris
Journal:  Clin Immunol       Date:  2020-03-27       Impact factor: 3.969

9.  A comparative analysis of C57BL/6J and 6N substrains; chemokine/cytokine expression and susceptibility to laser-induced choroidal neovascularization.

Authors:  Gloriane Schnabolk; Kimberly Stauffer; Elizabeth O'Quinn; Beth Coughlin; Kannan Kunchithapautham; Bärbel Rohrer
Journal:  Exp Eye Res       Date:  2014-10-13       Impact factor: 3.467

10.  Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine.

Authors:  Nicholas Fowler; Noe R Mendez Martinez; Bernardo Velazquez Pallares; Ramiro S Maldonado
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.